| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcb3c50149b5ac2c624ea8f89a3139da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88e7ad84331cedbf8c0b224b12331268
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8521133ea59dcba3051eda14b4b00377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0e688f4f0f360c3093469970677fdbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5dd3b68a08d855bf995dbbfdcc1173f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f09690f7cdb6848928d9f5401146965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59689d3cb47f9b92f8cd75b789f3fcbb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E01B25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 |
| filingDate |
2006-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e0ebc3026eab438e55004dbafc9fd1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a07cb7cb2310cd6a5ca2d15a1b0fca8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39de4ac24b3209e0e76ff9e19248097e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f107daa7d8ceb98e9b313bff1773e427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_babc2032fab134cf4607aa955304445b |
| publicationDate |
2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007086631-A1 |
| titleOfInvention |
Recombinant adenoviruses capable of regulating angiogenesis |
| abstract |
The present invention relates to a recombinant adenovirus capable of regulating angiogenesis, which comprises (a) an adenoviral UR (inverted terminal repeat) nucleotide sequence; and (b) a transcription regulatory sequence for a VEGF- A (vascular endothelial growth factor-A) gene comprising (i) a nucleotide sequence encoding a DNA binding domain comprising a zinc finger domain to bind to a site in a VEGF-A promoter sequence as set forth in nucleotides 1-2362 of SEQ ID NO:1, and (ii) a transcription activation domain or a transcription inhibitory domain linked to the nucleotide sequence encoding the DNA binding domain; and a pharmaceutical composition comprising the recombinant adenovirus. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107723279-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109576231-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109576231-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107723279-A |
| priorityDate |
2006-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |